Blood Glucose Monitoring Devices Market (2026 - 2033) Size, Share & Trends Analysis Report By Product (Self-Monitoring Devices, Continuous Glucose Monitoring Devices), By Connectivity, By End Use, By Region, And Segment Forecasts

Blood Glucose Monitoring Devices Market Summary

The global blood glucose monitoring devices market size was estimated at USD 15.53 billion in 2025 and is projected to reach USD 30.18 billion by 2033, growing at a CAGR of 8.8% from 2026 to 2033. The market is primarily influenced by the growing prevalence of diabetes and growing elderly population susceptible to conditions such as diabetes.

In addition, market growth is driven by rising awareness of preventive measures for diabetes and the introduction of new products. Diabetes, a widespread and increasing global concern, is characterized by the pancreas' inability to efficiently produce insulin, leading to elevated blood glucose levels. Moreover, the technology associated with blood glucose monitoring not only aids immediate intervention but also serves as a valuable tool for patient education on diabetes and its effective management.

The rising global prevalence of diabetes is anticipated to drive strong market demand during the forecast period. According to the Institute for Health Metrics and Evaluation (June 2023), over 500 million people worldwide currently live with diabetes, impacting individuals across all demographics. With a global prevalence of 6.1%, diabetes ranks among the top 10 causes of death and disability. North Africa and the Middle East lead with a 9.3% prevalence, which is expected to increase to 16.8% by 2050. In Latin America and the Caribbean, the prevalence is projected to rise to 11.3%.

In addition, market growth is driven by rising awareness of preventive measures for diabetes and the introduction of new products. Diabetes, a widespread and growing global concern, is characterized by the pancreas' inability to efficiently produce insulin, leading to elevated blood glucose levels. According to the International Diabetes Federation, approximately 537 million individuals were diagnosed with diabetes in 2021, and projections indicate an anticipated rise to 643 million by 2030 and 783 million by 2045.

Blood glucose monitoring (BGM) devices play a crucial role in supporting individuals with diabetes in numerous ways. Initially, they empower both patients and healthcare professionals to identify elevated or reduced blood glucose levels, enabling timely adjustments to treatment plans. This capability serves as a protective measure by promptly confirming acute hypoglycemia or hyperglycemia, ensuring the well-being of patients. In addition, these devices enhance self-care practices, offering individuals greater control over their diabetes management. Moreover, the technology associated with blood glucose monitoring not only aids in immediate intervention but also serves as a valuable tool for patient education on diabetes and its effective management.

The prevalence of diabetes tends to increase with age, and older adults are more susceptible to developing diabetes or experiencing complications related to the disease. As the geriatric population increases, so does the pool of individuals at risk of diabetes, creating a greater demand for blood glucose monitoring devices. For instance, based on the National Diabetes Statistics Report, in 2021, in the U.S. 27.2 million adults aged 65 years or older had prediabetes. Studies have shown that real-time continuous glucose monitoring (CGM) is effective and safe in adults aged 65 years and older with type 2 diabetes. Participants aged 65 years and above showed a significant improvement in their hemoglobin A1c (HbA1c) levels, which indicates better control of blood glucose levels when using CGM compared to blood glucose monitoring (BGM). These results underscore the potential value of CGM devices as a beneficial tool for effectively managing diabetes in the elderly population.

The COVID-19 pandemic has significantly impacted the market. The pandemic highlighted healthcare disparities and technological importance, including BGM devices. Regulatory changes, such as relaxed requirements for obtaining continuous glucose monitoring (CGM), have increased access to these devices, particularly benefiting those who can benefit from the technology. Furthermore, the use of real-time continuous glucose monitoring (rtCGM) was observed during lockdowns for improved glycemic control, reducing the time in range & glucose variability, thereby significantly boosting the overall market growth.

Market Concentration & Characteristics

The innovation in blood glucose monitoring devices has been substantial, leading to growth in the market. This includes developments in microminiaturization, new sensor technologies, and transcutaneous devices.

Several market players, such as Medtronic Plc, F. Hoffmann-La Roche Ltd., and Abbott, are involved in merger and acquisition activities. Through M&A activity, these companies can expand their geographic reach and enter new territories.

Regulations significantly shape the growth and development of the blood glucose monitoring devices market. For instance, the European Union's regulation requiring evidence of state-of-the-art medicine for CE marking has raised concerns that Simple Blood Glucose (SMBG) meters may no longer qualify as a state-of-the-art method for self-monitoring.

Potential substitutes for blood glucose monitoring devices include the Eversense CGM, a subcutaneous implant device made by Senseonics, which measures glucose in interstitial fluids every 5 minutes and sends the data to a smartphone. This helps patients to manage their diabetes.

BGM device manufacturers are strategically expanding regionally to tap into growing markets and address diverse healthcare needs. This approach allows customization of products to meet regional preferences and regulatory requirements, fostering broader accessibility.

Product Insights

The self-monitoring blood glucose devices segment led the market and accounted for a share of 66.0% in 2025, due to its affordability and user-friendly nature. Self-monitoring of blood glucose (SMBG) plays a crucial role in daily diabetes management using a glucose meter to measure blood sugar levels. In addition, other SMBG devices such as testing strips and lancets are used to manage glucose levels individually. The development and launch of a novel SMBD device are anticipated to drive segment growth during the forecast period.

The adoption of blood glucose meters is steadily on the rise, attributed to their numerous benefits, including portability and precision. Companies in the market are concentrating on enhancing these devices and are launching compact blood glucose meters. Among the smallest advanced technology blood glucose meters available in the UK are Abbott Diabetes Care’s Freestyle Lite, Bayer’s CONTOUR NEXT USB, Lifescan’s One Touch UltraEasy, Accu-Chek Aviva Nano, Accu-Chek Mobile, and TRUEone blood glucose meter. The emergence of these small, discreet, and user-friendly blood glucose meters is anticipated to drive growth in this segment throughout the forecast period.

The continuous blood glucose monitoring (CBGM) devices segment is expected to show lucrative growth during the forecast period. CBGM is a critical tool for managing type 1 diabetes, especially in preventing severe hypoglycemia. These devices continuously monitor blood sugar levels, offering real-time readings every five minutes. Sub-divided into insulin pumps, sensors, and transmitters/receivers, CBGM employs a small sensor under the skin to measure glucose levels, with the transmitter wirelessly transmitting data to a monitor.

Connectivity Insights

The Bluetooth-enabled devices segment dominated the blood glucose monitoring devices market with a revenue share of 50.2% in 2025. This can be attributed to the increased accuracy of these devices in tracking glucose levels, reduced manual entry errors, and enhanced patient engagement through user-friendly interfaces. Furthermore, these devices can help patients adhere more closely to their treatment plans by providing timely alerts when glucose levels exceed the target range.

Bluetooth-enabled BGM devices allow individuals with diabetes to monitor their blood glucose levels conveniently and efficiently by wirelessly transmitting data to smartphones, tablets, or computers. The integration of Bluetooth technology facilitates real-time data sharing, enabling users to track their glucose levels over time and share this information with healthcare providers for better management of their condition.

The benefits of using Bluetooth-enabled blood glucose monitors include increased accuracy in tracking glucose levels, reduced manual entry errors, and enhanced patient engagement through user-friendly interfaces. Furthermore, these devices can help patients adhere more closely to their treatment plans by providing timely alerts when glucose levels exceed the target range. Some advanced models even integrate CGM systems that provide real-time readings without frequent finger pricks.

End Use Insights

The hospital segment led the market in 2025 and accounted for a share of 41.1% of the global revenue. The rising cases of hospitalization of diabetic patients and increased hospital expenditures have led to increased adoption of BGM devices as they provide practitioners with instantaneous, reliable data and enhance patients' quality of life by providing accurate treatment plans. This adoption extends to both outpatient and inpatient hospital settings, where hospitals benefit from additional provisions for storing and transferring patient information. Notably, during the COVID-19 pandemic, the FDA permitted the use of CGM devices in hospitals, indicating potential future growth in this segment in anticipation of similar healthcare challenges.

The home care segment is expected to witness lucrative growth from 2026 to 2033. The landscape of home-based glucose monitoring has been transformed by SMBG, emerging as the predominant method globally for short-term glucose level tracking. SMBG empowers individuals, whether with or without diabetes, to measure their blood sugar levels conveniently at home. This approach enables patients to assess the impact of their treatment strategies, encompassing factors including diet, insulin, exercise, and stress management, based on the obtained readings.

Regional Insights

North America blood glucose monitoring systems market accounted for a share of 38.0% in 2025. The region boasts a large pool of target population with a high prevalence of diabetes, driving the demand for innovative and technologically advanced blood glucose monitoring devices. In addition, well-established healthcare infrastructure, widespread awareness about diabetes management, and favorable reimbursement policies contribute to the high demand for products in the region.

U.S. Blood Glucose Monitoring Devices Market Trends

The blood glucose monitoring devices market in the U.S. held the largest share in 2025 owing to key factors, such as the rising prevalence of diabetes in the country. According to the Centers for Disease Control and Prevention, in 2020, 34.2 million individuals in the U.S., or 10.5% of the population, had diabetes. Furthermore, poor diet, rising obesity cases, and supportive government measures are projected to have a positive impact on market growth.

Europe Blood Glucose Monitoring Devices Market Trends

The Europe regional market is expected to witness significant growth over the forecast period due to an increasing awareness of and demand for product devices in the region.

The UK blood glucose monitoring devices market is expected to grow over the forecast period due to a range of factors, such as the growing preference of patients for BGM as a tool for their treatment, supportive reimbursement policies, and the presence of key market players in the country.

Blood glucose monitoring devices market in Germany is expected to grow over the forecast period. This growth can be attributed to several factors, such as increasing number of obese populations, which are more susceptible to diabetes, and the growing disease burden in the country

France blood glucose monitoring devices market is expected to grow significantly over the forecast period. This growth can be attributed to a range of factors, such as poor diet habits, unhealthy lifestyles, high prevalence of disease, and well-established healthcare infrastructure.

Blood glucose monitoring devices market in Spain growth is driven by a rising prevalence of diabetes and an increasing focus on effective diabetes management. For instance, as per the International Diabetes Federation (IDF), in 2021, there were around 5,141,300 cases of diabetes among adults. In this country, primary care physicians monitor most diabetic patients and work closely with endocrinologists to manage more complex cases.

Asia Pacific Blood Glucose Monitoring Devices Market Trends

The blood glucose monitoring devices market in Asia Pacific is expected to grow at the fastest CAGR from 2026 to 2033. The region's substantial population, particularly in countries like China and India, contributes to a large pool of potential patients. In addition, improving healthcare infrastructure, a growing middle-class population with higher healthcare expenditures, and technological advancements in blood glucose monitoring devices are creating a conducive environment for market expansion.

China blood glucose monitoring devices market is accounted for the largest share of the regional market in 2025. The country's vast population, coupled with a rising incidence of diabetes, creates a substantial market demand. For instance, as per the Statista report, in 2021, China documented the highest global count of diabetes patients, reaching 129 million individuals, constituting approximately 8.5% of the population.

Blood glucose monitoring devices market in Japan is expected to grow over the forecast period. Due to the increasing geriatric population, there is a high prevalence of age-related diabetes, which is likely to boost the demand for BGM devices to monitor glucose levels.

India blood glucose monitoring devices market is expected to grow over the forecast period. India’s large population coupled with an increasing prevalence of diabetes and improving healthcare infrastructure are the factors driving market growth in the country.

Blood glucose monitoring devices market in Indonesia is expected to grow at a lucrative CAGR over the forecast period. As of 2025, the Indonesia diabetes care devices market, including both monitoring and insulin delivery, is expected to grow steadily, though it faces unique regional challenges regarding affordability and infrastructure. The Indonesia blood glucose monitoring devices market is entering a phase of significant transformation, driven by an alarming rise in diabetes prevalence, with over 105 of adult population affected, and a shift from traditional "finger-stick" tests to digital & continuous monitoring.

Latin America Blood Glucose Monitoring Devices Market Trends

Blood glucose monitoring devices market in Latin America is growing, especially country like Brazil where 32% of people living with diabetes remain undiagnosed. In addition, only 25% of individuals with diabetes were able to achieve the therapeutic goal of glycated hemoglobin (HbA1c) <7% before the pandemic, as recommended by the Brazilian Diabetes Society (SBD). Thus, the demand for advanced devices and other home health applications for diabetes is high and is fueling the market growth.

MEA Blood Glucose Monitoring Devices Market Trends

The blood glucose monitoring devices market in MEA is expected to witness rapid growth due to the increased prevalence of diabetes and a rapidly aging population, as well as growing demand for home-based monitoring devices. According to the International Diabetes Federation (IDF), the Middle East accounted for the second-highest deaths due to diabetes among patients under 60 years.

South Africa blood glucose monitoring devices market is anticipated to witness growth during the forecast period. According to the IDF Diabetes Atlas 2021, diabetes affects around one in nine adults in South Africa. There is a gradual shift towards advanced glucose monitoring technologies. CGMs and newer blood glucose meters are gaining traction, although their adoption is still in the early stages compared to more developed markets. The integration of blood glucose monitoring devices with digital health tools, including mobile apps and cloud-based platforms, is starting to gain momentum.

Blood glucose monitoring devices market in Saudi Arabia is expanding significantly, driven by a growing patient base and rising demand for continuous and self-monitoring solutions. According to the International Diabetes Federation’s 2021 report, diabetes prevalence in Saudi Arabia remains alarmingly high, with over one in ten individuals affected. The report further projects that the number of people living with diabetes could nearly double by 2045, estimating that around 4.27 million people in the country currently have the condition. This sharp rise in diabetes cases, particularly type 2 diabetes, is driven by a mix of socioeconomic, demographic, environmental, and genetic factors.

The UAE blood glucose monitoring devices market is witnessing growth due country’s government has been implementing favorable policies to attract foreign investments aimed at enhancing healthcare quality and strengthening the overall healthcare industry. These initiatives create substantial growth opportunities for manufacturers to expand their presence within the country. For example, in September 2021, the HealthPlus Diabetes & Endocrinology Center in Abu Dhabi introduced the artificial pancreas device (MiniMed 780G), a next-generation smart insulin pump designed for type 1 diabetes patients. Such advancements, coupled with government support, are driving innovation and fueling the market growth.

Key Blood Glucose Monitoring Devices Company Insights

Some of the key players operating in the market include Abbott, Medtronic Plc., and Novo Nordisk. The company's primary strategies involve a comprehensive understanding of the strengths and weaknesses of major market participants, anticipation of future market trends, identification of opportunities and challenges, and proactive decision-making based on insights into emerging technologies and evolving consumer preferences. Insulet Corporation and Glysens. are some of the emerging market players in the market.These players focus on niche segments, leveraging specialized technologies to differentiate themselves.

Recent Development

• In March 2023, Abbott received U.S. FDA approval for the integration of its FreeStyle Libre 3 and FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system sensors with automated insulin delivery (AID) systems. Both the FreeStyle Libre 3 and FreeStyle Libre 2 sensors are currently accessible in the U.S., with approval for use in individuals aged four years and older

• In February 2023, Ascensia Diabetes Care Holdings AG, the developer of the CONTOUR BGM system portfolio, globally partnered with SNAQ, a mobile application offering nutritional insights for individuals managing diabetes

• In November 2021, Intuity Medical launched the POGO automatic blood glucose monitoring system for diabetes patients in the U.S. This device launch helps improve patient's quality of life

Blood Glucose Monitoring Devices Market Report Scope

Global Blood Glucose Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global blood glucose monitoring devices market report on the basis of product, connectivity, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Self-Monitoring Devices

    • Blood Glucose Meters

      • Traditional BGMs

      • Smart BGMs

    • Testing Strips

    • Lancets

  • Continuous Glucose Monitoring (CGM) Devices

    • Sensors

    • Transmitter and Receiver

    • Insulin Pumps

      • Traditional Insulin Pumps

      • Smart Insulin Pumps

• Connectivity Outlook (Revenue, USD Million, 2021 - 2033)

  • Bluetooth-Enabled Devices

  • Wi-Fi-Enabled Devices

  • Near Field Communication (NFC) Devices

  • USB Connectivity Devices

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals

  • Home Care

  • Diagnostic Centers

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

    • Mexico

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait